Extract from the Register of European Patents

EP About this file: EP1100529

EP1100529 - THYMOSIN BETA 4 PROMOTES WOUND REPAIR [Right-click to bookmark this link]
StatusPatent maintained as amended
Status updated on  23.07.2010
Database last updated on 09.04.2026
Most recent event   Tooltip23.07.2010Patent maintained (B2 publication)published on 25.08.2010  [2010/34]
Applicant(s)For all designated states
The Government of the United States of America, as repres. by the Secretary of Health and Human Services, Nat. Inst. of Health
Office of Technology Transfer Suite 325 6011 Executive Boulevard
Rockville, MD 20852-3804 / US
[2010/34]
Former [2004/46]For all designated states
The Government of the United States of America, as repres. by the Secretary of Health and Human Services, Nat. Inst. of Health
Office of Technology Transfer Suite 325 6011 Executive Boulevard
Rockville, MD 20852-3804 / US
Former [2001/21]For all designated states
THE GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES
c/o National Institutes of Health, Office of Technology Transfer, 6011 Executive Boulevard, Suite 325
Rockville, MD 20852-3804 / US
Inventor(s)01 / KLEINMAN, Hynda, K., Building 30, Room 433
30Convent Drive, MSC-4370
Bethesda, MD 20892 / US
02 / GOLDSTEIN, Allan, George Washington University
2300 I Street, N.W.
Washington, DC 20037 / US
03 / MALINDA, Katherine, M., Building 30, Room 433
30 Convent Drive, MSC-4370
Bethesda, MD 20892 / US
04 / SOSNE, Gabriel
25341 Ronald Court
Oak Park, MI 48237 / US
 [2004/46]
Former [2001/21]01 / KLEINMAN, Hynda, K., Building 30, Room 433
30Convent Drive, MSC-4370
Bethesda, MD 20892 / US
02 / GOLDSTEIN, Allan, George Washington University
2300 I Street, N.W.
Washingotn, DC 20037 / US
03 / MALINDA, Katherine, M., Building 30, Room 433
300 Convent Drive, MSC-4370
Bethesda, MD 20892 / US
04 / SOSNE, Gabriel
25341 Ronald Court
Oak Park, MI 48237 / US
Representative(s)Klunker, Hans-Friedrich
Klunker Schmitt-Nilson Hirsch Patentanwälte Destouchesstrasse 68
80796 München / DE
[N/P]
Former [2005/51]Klunker, Hans-Friedrich
Patentanwälte Klunker . Schmitt-Nilson . Hirsch Winzererstrasse 106
80797 München / DE
Former [2001/21]Wakerley, Helen Rachael
Reddie & Grose, 16 Theobalds Road
London WC1X 8PL / GB
Application number, filing date99937654.429.07.1999
[2001/21]
WO1999US17282
Priority number, dateUS19980094690P30.07.1998         Original published format: US 94690 P
[2001/21]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO0006190
Date:10.02.2000
Language:EN
[2000/06]
Type: A1 Application with search report 
No.:EP1100529
Date:23.05.2001
Language:EN
The application published by WIPO in one of the EPO official languages on 10.02.2000 takes the place of the publication of the European patent application.
[2001/21]
Type: B1 Patent specification 
No.:EP1100529
Date:06.04.2005
Language:EN
[2005/14]
Type: B2 New European patent specification 
No.:EP1100529
Date:25.08.2010
Language:EN
[2010/34]
Search report(s)International search report - published on:EP10.02.2000
ClassificationIPC:A61K38/22, A61K39/395, A61P17/02
[2004/45]
CPC:
A61K38/2292 (EP,US); A61K38/08 (EP,US); A61K38/1841 (EP,US);
A61K45/06 (US); A61K9/0048 (US); A61P17/02 (EP);
A61P29/00 (EP); A61P9/00 (EP); A61P9/10 (EP);
Y10S930/18 (EP,US) (-)
C-Set:
A61K38/08, A61K2300/00 (US,EP);
A61K38/1841, A61K2300/00 (US,EP);
A61K38/2292, A61K2300/00 (EP,US)
Former IPC [2001/21]A61K38/22, A61K39/395
Designated contracting statesAT,   BE,   CH,   CY,   DE,   DK,   ES,   FI,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   SE [2001/21]
Extension statesALNot yet paid
LTNot yet paid
LVNot yet paid
MKNot yet paid
RONot yet paid
SINot yet paid
TitleGerman:THYMOSIN BETA 4 STIMULIERT WUNDHEILUNG[2001/21]
English:THYMOSIN BETA 4 PROMOTES WOUND REPAIR[2001/21]
French:AMELIORATION DE LA GUERISON DES BLESSURES PAR LA THYMOSINE BETA 4[2001/21]
Entry into regional phase28.02.2001National basic fee paid 
28.02.2001Designation fee(s) paid 
28.02.2001Examination fee paid 
Examination procedure10.02.2000Request for preliminary examination filed
International Preliminary Examining Authority: EP
28.02.2001Examination requested  [2001/21]
01.05.2001Amendment by applicant (claims and/or description)
28.06.2001Despatch of a communication from the examining division (Time limit: M06)
31.12.2001Reply to a communication from the examining division
18.01.2002Despatch of a communication from the examining division (Time limit: M04)
24.05.2002Reply to a communication from the examining division
28.06.2002Despatch of a communication from the examining division (Time limit: M06)
23.12.2002Reply to a communication from the examining division
17.03.2003Despatch of a communication from the examining division (Time limit: M06)
01.08.2003Reply to a communication from the examining division
12.11.2003Despatch of a communication from the examining division (Time limit: M01)
12.12.2003Reply to a communication from the examining division
27.04.2004Despatch of a communication from the examining division (Time limit: M04)
27.08.2004Reply to a communication from the examining division
29.09.2004Communication of intention to grant the patent
28.01.2005Fee for grant paid
28.01.2005Fee for publishing/printing paid
Divisional application(s)EP04077891.2   Application deemed to be withdrawn  : 23.10.2004
EP04078459.7  / EP1591128
EP10186120.1  / EP2311485
Opposition(s)Opponent(s)01  06.01.2006  19.01.2006  ADMISSIBLE
Grannus Biosciences Limited
191 West George Street Glasgow
G2 2LD / GB
Opponent's representative
Smaggasgale, Gillian Helen, et al, et al
WP Thompson
138 Fetter Lane
London EC4A 1BT / GB
 [N/P]
Former [2006/10]
Opponent(s)01  06.01.2006  19.01.2006  ADMISSIBLE
Grannus Biosciences Limited
191 West George Street Glasgow
G2 2LD / GB
Opponent's representative
Smaggasgale, Gillian Helen, et al, et al
W.P. Thompson & Co, 55 Drury Lane
London WC2B 5SQ / GB
14.02.2006Invitation to proprietor to file observations on the notice of opposition
21.08.2006Reply of patent proprietor to notice(s) of opposition
10.12.2009Legal effect of interlocutory decision in opposition
10.12.2009Date of oral proceedings
21.12.2009Despatch of interlocutory decision in opposition
21.12.2009Despatch of minutes of oral proceedings
08.04.2010Despatch of communication that the patent will be maintained as amended
07.07.2010Fee for printing new specification paid
Fees paidRenewal fee
25.07.2001Renewal fee patent year 03
12.07.2002Renewal fee patent year 04
23.07.2003Renewal fee patent year 05
22.07.2004Renewal fee patent year 06
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipBE06.04.2005
GR06.07.2005
CY29.07.2005
[2007/23]
Former [2006/14]BE06.04.2005
GR06.07.2005
Former [2006/13]BE06.04.2005
Cited inInternational search[XY]   MALINDA K M ET AL: "Thymosin beta 4 stimulates directional migration of human umbilical vein endothelial cells.", FASEB JOURNAL, vol. 11, no. 6, May 1997 (1997-05-01), pages 474 - 481, XP002125695 [X] 1,2,5-8,13,16-19,23-28,31-35,38,53,57-64 * the whole document *[Y] 3,4,11,12,14,15,22,29,30,36,37
 [XY]   SUN H -Q ET AL: "BETA-THYMOSINS ARE NOT SIMPLE ACTIN MONOMER BUFFERING PROTEINS. INSIGHTS FROM OVEREXPRESSION STUDIES", JOURNAL OF BIOLOGICAL CHEMISTRY, vol. 271, no. 16, April 1996 (1996-04-01), pages 9223 - 9230, XP002041936, ISSN: 0021-9258 [X] 1,2,8-10,13,19-21,23,24,26,53,60,62,63,45,46 * page 9223, column 1, line 15 - line 18 * * page 9229; figure 3 * * page 9224, section "Quantitative Immunoblotting" * * page 9227, column 1, line 5 - page 9228, column 1, line 3 * [Y] 11,22,36

DOI:   http://dx.doi.org/10.1074/jbc.271.16.9223
 [YA]   NIMNI M E: "Polypeptide growth factors: targeted delivery systems", BIOMATERIALS, vol. 18, no. 18, 1997, pages 1201 - 1225, XP004086390, ISSN: 0142-9612 [Y] 3,4,11,12,14,15,22,29,30,36,37 * page 1210, column 1, line 15 - line 53 * * page 1203 - page 1211 * * page 1205, section "Keloid and hypertrophic scars" * * pages 1215-1216, sections "Delivery of growth factors in wound healing" and "Some novel and potentially useful approaches for local delivery of growth factors" *[A] 38-40,54-61,64,41-44

DOI:   http://dx.doi.org/10.1016/S0142-9612(97)00050-1
 [Y]   FRANK, S ET AL: "Regulation of vascular endothelial growth factor expression in cultured keratinocytes and implications for normal and impaired wound healing", J. BIOL. CHEM., vol. 270, no. 21, May 1995 (1995-05-01), pages 12607 - 12613, XP002125696 [Y] 11,12,22,36,37 * page 12607, column 2, line 13 - line 26 * * page 12609, column 2, line 7 - line 12 *

DOI:   http://dx.doi.org/10.1074/jbc.270.21.12607
 [A]   SABOLINSKI M L ET AL: "Cultured skin as a 'smart material' for healing wounds: experience in venous ulcers", BIOMATERIALS, vol. 17, no. 3, 1996, pages 311 - 320, XP004032797, ISSN: 0142-9612 [A] 26 * Introduction *

DOI:   http://dx.doi.org/10.1016/0142-9612(96)85569-4
 [A]   HANNAPPEL E & WARTENBERG F: "Actin-sequestring ability of thymosin beta 4, thymosin beta 4 fragments and thymosin beta 4-like peptides as assessed by the DNAse I inhibition assay", BIOL. CHEM., vol. 374, February 1993 (1993-02-01), pages 117 - 122, XP002118663 [A] 1,2,9,10,20,21,23,24,62,63 * page 121, column 1, line 8 - column 2, line 17 *
ExaminationWO9423739
 WO9509646
 JPH04234325
 EP0450240
   DATABASE WPI Week 199240, Derwent World Patents Index; Class B04, AN 1992-327505 [A]
by applicant  NODA ET AL., ENDOCRINOLOGY, vol. 124, 1989, pages 2991 - 2995 [X] 1,2,5-8,13,16-19,23-28,31-35,38,53,57-64 * the whole document * [Y] 3,4,11,12,14,15,22,29,30,36,37
   GOEY ET AL., J. LMMUNOL., vol. 143, 1989, pages 877 - 880 [X] 1,2,8-10,13,19-21,23,24,26,53,60,62,63,45,46 * page 9223, column 1, line 15 - line 18 * * page 9229; figure 3 * * page 9224, section "Quantitative Immunoblotting" * * page 9227, column 1, line 5 - page 9228, column 1, line 3 *[Y] 11,22,36
   PIETENPOL ET AL., PROC. NAT'L. ACAD SCI. USA, vol. 87, 1990, pages 3758 - 3762 [Y] 3,4,11,12,14,15,22,29,30,36,37 * page 1210, column 1, line 15 - line 53 * * page 1203 - page 1211 * * page 1205, section "Keloid and hypertrophic scars" * * pages 1215-1216, sections "Delivery of growth factors in wound healing" and "Some novel and potentially useful approaches for local delivery of growth factors" *[A] 38-40,54-61,64,41-44
   IGNOTZ ET AL., J. BIOL CHEM., vol. 261, 1986, pages 4337 - 4345 [A] 6,7,17,18,33,34,58,61,64
   MUSTOE ET AL., SCIENCE, vol. 237, 1987, pages 1333 - 1335 [Y] 11,12,22,36,37 * page 12607, column 2, line 13 - line 26 * * page 12609, column 2, line 7 - line 12 *
   ROSS R. ET AL., PROC NAT' ACAD SCI USA, vol. 71, no. 4, pages 1207 - 1210 [A] 41-44,47-49
   KOHLER N. ET AL., EXP. CELL RES., vol. 87, 1974, pages 297 - 301
   PIERCE, GF ET AL., J. EXP. MED., vol. 167, 1988, pages 974 - 987
   GROTENDORST, GR ET AL., J. CLIN. INVEST., vol. 76, 1985, pages 2323 - 2329 [A] 26 * Introduction *
   SPORN, MB ET AL., SCIENCE, vol. 219, 1983, pages 1329 [A] 1,2,9,10,20,21,23,24,62,63 * page 121, column 1, line 8 - column 2, line 17 *
   CECH, J.AMER.MED. ASSN., vol. 260, 1988, pages 3030
   HASSELHOFF, NATURE, vol. 334, 1988, pages 585
   DE MESMAEKER ET AL.: "Backbone modifications in oligonucleotides and peptide nucleic acid systems", CURR. OPIN. STRUCT. BIOL, vol. 5, 1995, pages 343 - 355
   GEWIRTZ, A.M. ET AL.: "Facilitating delivery of antisense oligodeoxynucleotides: Helping antisense deliver on its promise", PROC. NATL. ACAD SCI. U.S.A., vol. 93, 1996, pages 3161 - 3163
   STEIN, C.A.: "A discussion of G-tetrads 1996. Exploiting the potential of antisense: beyond phosphorothioate oligodeoxynucleotides", CHEM. AND BIOL., vol. 3, pages 319 - 323
   MANNINO ET AL., BIOTECHNIQUES, vol. 6, 1988, pages 682
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.